RAPT Therapeutics, Inc. (RAPT) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | -12.46M | -11.27M | -52.41M | -10.44M | -17.62M | -28.15M | -27.08M | -27.75M | -21.88M | -28.81M | -18.6M | -22.85M | -17.15M | -15.2M | -15.58M | -20.68M | -12.52M | -13.92M | -13.91M | -15.37M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | -1715.01% | -2430.27% | -2735.58% | -1295.96% | -1601.38% | -1138.3% | -1180.18% |
| Operating CF Growth % | 29.3% | 59.97% | -93.52% | 62.39% | 19.48% | 2.27% | -45.6% | -21.47% | -27.61% | -89.59% | -19.41% | -10.48% | -36.98% | -9.19% | -11.99% | -34.59% | -25.78% | -116.52% | -59.06% | -170.15% |
| Net Income | -17.58M | -17.64M | -17.16M | -53.25M | -18.43M | -27.66M | -30.52M | -30.88M | -31.37M | -25.28M | -29.27M | -22.95M | -21.23M | -19.18M | -20.47M | -17.93M | -18.65M | -16.11M | -16.51M | -12.73M |
| Depreciation & Amortization | 205K | 228K | 252K | 287K | 297K | 305K | 314K | 323K | 908K | 269K | 883K | 252K | 260K | 274K | 689K | 231K | 200K | 256K | 280K | 265K |
| Stock-Based Compensation | 5.03M | 4.54M | 4.65M | 4.59M | 4.56M | 5.38M | 5.4M | 4.43M | 0 | 4.24M | 0 | 3.02M | 2.87M | 2.67M | 0 | 2.09M | 0 | 2.89M | 2.69M | 2.56M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.72M |
| Other Non-Cash Items | -257K | -256K | -109K | 54K | 32K | -164K | -399K | -640K | 2.77M | -1.58M | 2.65M | -265K | 646K | 1.14M | 2.84M | 407K | 2.9M | 282K | 256K | -12.68M |
| Working Capital Changes | 145K | 1.86M | -40.04M | 37.88M | -4.08M | -6.02M | -1.88M | -990K | 5.81M | -6.46M | 7.13M | -2.91M | 315K | -99K | 1.36M | -5.48M | 3.03M | -1.23M | -619K | -5.5M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.01M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.38M |
| Change in Payables | 328K | 4.47M | -4.57M | 3.09M | -4.39M | -6.43M | -728K | -71K | 6.38M | -6.25M | 7.28M | -263K | 673K | 1.41M | 1.89M | -2.62M | 3.08M | 109K | 362K | -2.82M |
| Cash from Investing | 8.47M | -7.26M | -57.06M | -843K | 18.45M | 19.21M | 15.89M | 20.64M | 25.75M | 32.44M | 25.31M | -41.27M | -17.6M | -10.46M | 23.84M | -15.89M | -14.17M | -63.69M | 12.41M | 15.49M |
| Capital Expenditures | 0 | -40K | -43K | -1K | -17K | 1K | -105K | -67K | -66K | -233K | -759K | -49K | -81K | -566K | -149K | -394K | -70K | -64K | -227K | -174K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 63.88% | 23.24% | 52.12% | 7.25% | 7.36% | 18.58% | 13.36% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41.22M | 17.52M | 9.89M | 0 | 0 | 0 | 0 | 0 | 8M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -41.22M | -17.52M | -9.89M | 0 | 0 | 0 | 0 | 0 | -8M |
| Cash from Financing | 36K | 161K | 0 | 143.12M | 0 | 701K | 9.04M | 458K | 106K | 767K | 116K | 75.36M | 5.25M | 50.44M | 132K | 601K | 472K | 139.11M | 1.3M | 4.56M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 36K | 161K | 0 | 1000K | 0 | 701K | 1000K | 458K | 106K | 0 | 116K | 1000K | 1000K | 1000K | 132K | 188K | 472K | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 77K | 0 | 0 | 67K | 0 | 0 | 767K | 0 | 334K | 272K | 654K | 0 | 413K | 0 | 1.02M | 121K | 485K |
| Net Change in Cash | -3.96M | -18.37M | -109.48M | 131.84M | 823K | -8.24M | -2.16M | -6.66M | 3.97M | 4.4M | 6.82M | 11.24M | -29.5M | 24.79M | 8.39M | -35.97M | -26.22M | 61.5M | -198K | 4.69M |
| Free Cash Flow | -12.46M | -11.31M | -52.46M | -10.44M | -17.64M | -28.15M | -27.19M | -27.82M | -21.95M | -29.04M | -19.36M | -22.9M | -17.23M | -15.76M | -15.73M | -21.07M | -12.59M | -13.98M | -14.14M | -15.54M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | -1778.89% | -2453.51% | -2787.7% | -1303.21% | -1608.75% | -1156.87% | -1193.55% |
| FCF Growth % | 29.37% | 59.82% | -92.93% | 62.48% | 19.64% | 3.06% | -40.43% | -21.5% | -27.39% | -84.26% | -23.11% | -8.65% | -36.87% | -12.74% | -11.25% | -35.62% | -24.9% | -117.52% | -59.87% | -172.01% |
| FCF per Share | -0.46 | -0.42 | -1.95 | -1.79 | -3.63 | -5.79 | -5.63 | -5.80 | -4.58 | -6.06 | -4.05 | -5.13 | -4.09 | -4.05 | -4.25 | -5.71 | -3.41 | -4.37 | -4.55 | -5.06 |
| FCF Conversion (FCF/Net Income) | 0.71x | 0.64x | 3.05x | 0.20x | 0.96x | 1.02x | 0.89x | 0.90x | 0.70x | 1.14x | 0.64x | 1.00x | 0.81x | 0.79x | 0.76x | 1.15x | 0.67x | 0.86x | 0.84x | 1.21x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |